Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Halamek, L. P.
Right arrow Articles by Stevenson, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halamek, L. P.
Right arrow Articles by Stevenson, D. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Neonatal Hypoglycemia, Part II: Pathophysiology and Therapy

Louis P. Halamek, MD

Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, 750 Welch Road, Suite 315, Palo Alto, CA 94304

David K. Stevenson, MD

Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, CA

Contemporary research is elucidating both the molecular mechanisms of hypoglycemiainduced neuronal injury and its corresponding clinical manifestations. Recognizing and screening those neonates at highest risk of hypoglycemia-induced injury is an important skill for all physicians responsible for the care of newborns. Appropriate therapy, consisting of either oral or intravenous glucose, should never be delayed while one is awaiting laboratory confirmation of a "low" glucose level.

Clinical Pediatrics, Vol. 37, No. 1, 11-16 (1998)
DOI: 10.1177/000992289803700102
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
T. Urakami, S. Kubota, Y. Nitadori, K. Harada, M. Owada, and T. Kitagawa
Annual Incidence and Clinical Characteristics of Type 2 Diabetes in Children as Detected by Urine Glucose Screening in the Tokyo Metropolitan Area
Diabetes Care, August 1, 2005; 28(8): 1876 - 1881.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
L. Meloy, G. Miller, M. H. Chandrasekaran, C. Summitt, and G. Gutcher
Accuracy of Glucose Reflectance Testing for Detecting Hypoglycemia in Term Newborns
Clinical Pediatrics, November 1, 1999; 38(12): 717 - 724.
[Abstract] [PDF]